EDMILSON CORREIA, Ph.D.
Microbiologist Pathogen Identification & Characterization Regulated Laboratory Testing Public Health & Food Safety Eagle Mountain, UT 385-***-**** ***********@*****.*** linkedin.com/in/edmilsoncorreia US Permanent Resident / Work Authorized
PROFESSIONAL SUMMARY
Ph.D.-trained Microbiologist with extensive laboratory experience isolating, identifying, and characterizing pathogenic microorganisms using both culture-based methods (plating, incubation, staining, colony isolation) and qPCR-based molecular detection. Seven peer-reviewed publications on dermatophyte identification, biofilm formation, and antimicrobial/antifungal susceptibility testing. Combines this bench-science depth with regulated laboratory experience — GLP/cGMP-compliant sample testing, documentation, and quality-system recordkeeping — from both pharmaceutical QC and pharmacy operations, and is quick to adapt to new accreditation frameworks such as ISO 17025:2017. Seeking to bring this combination of pathogen-detection expertise and regulated-testing discipline to the Dairy, Meat, and Specialized Product programs as a Microbiologist II/I with the Utah Department of Agriculture and Food.
CORE COMPETENCIES
● Pathogen Detection & Isolation: qPCR-Based Pathogen Detection, Bacterial & Fungal Culture Isolation, Plate Counts, Colony/Species Identification, Biofilm Analysis, Aseptic Technique
● Molecular Methods: Real-Time PCR & RT-qPCR, Nucleic Acid Extraction, Serial Dilution, Gel Electrophoresis, Spectrophotometry, Reagent & Media Preparation
● Regulated Laboratory Practice: GLP-Compliant Testing & Documentation, Chain-of-Custody & Sample Traceability, SOP Adherence, Environmental Monitoring, Equipment Calibration & Maintenance
● Quality Systems: cGMP/GLP Standards, Working Familiarity with ISO 17025 Principles, Root-Cause Investigations, Data Integrity & Defensible Reporting
● Scientific Communication: Technical Writing, Peer-Reviewed Publication, Data Analysis, Cross-Functional Collaboration PROFESSIONAL EXPERIENCE
Quality Control Technologist II bioMérieux (BioFire Diagnostics) Sep 2025 – Present
● Perform routine and specialized microbiological testing on raw materials, intermediates, and finished IVD products — including bioburden assays and environmental monitoring — under strict GLP/cGMP and quality-system requirements.
● Maintain accurate, defensible laboratory records and documentation supporting product release, traceability, and audit readiness.
● Investigate testing anomalies: identify root causes, author technical investigation reports, and communicate findings cross- functionally.
● Support laboratory systems integrity through equipment calibration, qualification, and preventive maintenance. Production Operator Commercial Metals Company (CMC) Mar 2022 – Oct 2025
● Operated high-volume industrial equipment in a safety-critical manufacturing environment while sustaining scientific development: published peer-reviewed research (2023, 2024, 2026) and studied US regulatory laboratory frameworks. SARS-CoV-2 Diagnostic Collaborator University of Coimbra — Institute of Microbiology, Faculty of Medicine Apr 2020
– Dec 2020
● Processed clinical patient samples for RT-qPCR diagnostic testing in a BSL-2/3 environment, executing nucleic acid extraction and amplification protocols under strict biosafety and chain-of-custody requirements.
● Maintained rigorous documentation and data confidentiality under high-throughput, time-sensitive testing conditions. Academic Instructor University of Santiago / University of Cabo Verde Mar 2017 – Dec 2019
● Taught undergraduate and graduate courses in microbiology and related sciences; led local research initiatives.
● Advised and mentored students on theses and dissertations in Medicine, Nutrition, and Nursing. QC Analyst & Pharmacist Director InLab/Inpharma · Cape Verde Pharmacies Nov 2012 – Mar 2015
● Performed physicochemical and microbiological QC testing on pharmaceutical raw materials and finished products under GMP — sampling, testing, documentation, and batch release support.
● Managed full pharmacy operations, including controlled substance inventory, staff supervision, and regulatory compliance. EDUCATION & LANGUAGES
● Ph.D. in Biosciences (Microbiology) — University of Coimbra, Portugal, 2018–2024
● M.Sc. in Medical Microbiology and Bacteriology — Federal University of Ceará, Brazil, 2015–2016
● B.Sc. in Pharmacy (Pharmaceutical Sciences) — Université Mouloud Mammeri de Tizi-Ouzou, Algeria, 2007–2012 Languages: English (Fluent), Portuguese (Native), French (Fluent), Spanish (Professional), Creole (Native) PEER-REVIEWED PUBLICATIONS (7 TOTAL, PATHOGEN IDENTIFICATION & SUSCEPTIBILITY FOCUS)
● Lenha-Silva, A.F. et al.; Correia, E.E.M.; et al. (2026). Spent Coffee Grounds Extract Limits Bacterial Proliferation on Human Foot Skin Under Humid Conditions. Applied Sciences, 16, 1886.
● Correia, E.E.M.; Mota, M.; Veiga, L.V.A.d.M.; Fernandes, C.; Gonçalves, T. (2024). Predominance of Trichophyton soudanense as Agent of Dermatophytoses in Cape Verdean School-Age Children. Journal of Fungi, 10, 693.
● Fernandes, C.; Sousa-Baptista, J.; Lenha-Silva, A.F.; Calheiros, D.; Correia, E.; et al. (2023). Azorean Black Tea (Camellia sinensis) Antidermatophytic and Fungicidal Properties. Molecules, 28, 7775.
● Correia, E.E.M.; Figueirinha, A.; Rodrigues, L.; et al. (2023). Chemical Profile and Antidermatophytic, Anti-Inflammatory, Antioxidant and Antitumor Activities of Withania chevalieri A.E. Gonç. Ethanolic Extract. Plants, 12, 2502.
● Brilhante, R.S.N.; Correia, E.E.M.; et al. (2017). Quantitative and Structural Analyses of the In Vitro and Ex Vivo Biofilm- Forming Ability of Dermatophytes. Journal of Medical Microbiology, 66(8).
● Brilhante, R.S.N.; Correia, E.E.M.; et al. (2017). In Vitro Activity of Azole Derivatives and Griseofulvin Against Planktonic and Biofilm Growth of Clinical Isolates. Mycoses.
● Brilhante, R.S.N.; de Aguiar, F.R.M.; et al.; Correia, E.E.M.; et al. (2017). Antifungal Susceptibility of Sporothrix schenckii Complex Biofilms. Medical Mycology.